PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
28495793-3	2017	This suggests that targeting USP7 may have therapeutic potential even in tumors with defective p53 or ibrutinib resistance.	ibrutinib	102-111	ubiquitin specific peptidase 7	Mus musculus	29-33